Regional expiratory flow limitation studied with Technegas in asthma ==================================================================== * Riccardo Pellegrino * Alberto Biggi * Alberto Papaleo * Gianfranco Camuzzini * Joseph R. Rodarte * Vito Brusasco ## Abstract Regional expiratory flow limitation (EFL) may occur during tidal breathing without being detected by measurements of flow at the mouth. We tested this hypothesis by using Technegas to reveal sites of EFL. A first study (*study 1*) was undertaken to determine whether deposition of Technegas during tidal breathing reveals the occurrence of regional EFL in induced bronchoconstriction. Time-activity curves of Technegas inhaled during 12 tidal breaths were measured in four asthmatic subjects at control conditions and after exposure to inhaled methacholine at a dose sufficient to abolish expiratory flow reserve near functional residual capacity. A second study (*study 2*) was conducted in seven asthmatic subjects at control and after three increasing doses of methacholine to compare the pattern of Technegas deposition in the lung with the occurrence of EFL. The latter was assessed at the mouth by comparing tidal with forced expiratory flow or with the flow generated on application of a negative pressure.*Study 1* documented enhanced and spotty deposition of Technegas in the central lung regions with increasing radioactivity during tidal expiration. This is consistent with increased impaction of Technegas on the airway wall downstream from the flow-limiting segment.*Study 2* showed that both methods based on analysis of flow at the mouth failed to detect EFL at the time spotty deposition of Technegas occurred. We conclude that regional EFL occurs asynchronously across the lung and that methods based on mouth flow measurements are insensitive to it. * bronchoconstriction * methacholine * lung hyperinflation * negative expiratory pressure * flow-volume curve expiratory flow limitation (EFL) occurs in the intrathoracic airways whenever transpulmonary pressure achieves or exceeds the minimum value (critical pressure) necessary to generate maximal flow (9). In healthy subjects, EFL does not occur during tidal breathing at rest, because critical pressure is never achieved and expiratory flow is much less than maximal expiratory flow at the same lung volume. The difference between tidal and maximal flow is the flow reserve available for increasing ventilation. In airway obstruction, EFL may occur during tidal breathing, i.e., tidal expiratory flow becomes equal to maximal expiratory flow and flow reserve is abolished. Under these circumstances, ventilation can be increased or even maintained only by breathing at increased lung volumes, at which higher flows can be generated (17). As a result, functional residual capacity (FRC) increases above the relaxation volume of the respiratory system (dynamic lung hyperinflation). It has been suggested that dynamic hyperinflation may occur because the time constant of the respiratory system increases above the time available for tidal expiration (25). It has also been postulated that neural reflexes originated in the airways compressed downstream from the flow-limiting segments may prematurely activate the inspiratory muscles, thus stopping expiration before the relaxation volume of the respiratory system is attained (14,15). During induced bronchoconstriction, however, an increase in FRC was observed even in the absence of demonstrable EFL (23), thus suggesting that dynamic lung hyperinflation may be independent of EFL. An alternative explanation for this dissociation is that the methods currently used to detect EFL (9, 11, 14, 15, 23), which are based on measurements of mouth flows, are essentially insensitive to regional EFL. This study was designed to test the hypothesis that EFL during tidal breathing may occur inhomogeneously across the lung, thus remaining largely undetected by mouth flow measurements. For this purpose, we compared the classical physiological methods to detect EFL with radionuclear techniques capable of identifying regional EFL in vivo (20, 21). Specifically, we used Technegas, which is an ultrafine aerosol of carbon molecules labeled with 99mTc that distributes in the lung like an inert gas (3, 5, 6, 10,12) and remains trapped in the lung, wherever it is deposited, for a time long enough for a study like this to be performed (3). The study was conducted in asthmatic subjects during pharmacologically induced bronchoconstriction. ## METHODS ### Subjects We studied nine male asthmatic subjects in stable conditions (Table 1), who were all well familiar with pulmonary function tests. Asthma was diagnosed according to the American Thoracic Society guidelines (1). Four patients were under regular inhaled steroid therapy; the other five used inhaled short-acting bronchodilators only on demand, which were avoided for at least 12 h before each study day. The study was submitted to and approved by the Ethics Committee, and written consent was obtained from each subject. View this table: [Table 1.](http://jap.physiology.org/content/91/5/2190/T1) Table 1. Anthropometric and pulmonary function data of all 9 subjects ### Spirometry and Lung Volume Measurements A Vmax 6200 Autobox (SensorMedics, Yorba Linda, CA) was used to obtain standard spirometry and lung volume measurements. Flow was measured at the mouth by a mass flowmeter and numerically integrated to obtain inspired and expired volumes. Spirometry was performed according to the American Thoracic Society recommendations (2). Thoracic gas volume was measured while the subject was sitting in the body plethysmograph and panting against a closed shutter at a frequency slightly <1 Hz, with his cheeks gently supported by hands. Total lung capacity (TLC) was obtained as the sum of thoracic gas volume and the inspiratory capacity (IC) taken immediately after opening the shutter. FRC was corrected for any difference in volume between the four preceding end-tidal expirations and the volume at which the shutter was closed. Residual volume (RV) was obtained by subtracting vital capacity from TLC. Predicted values are from Quanjer et al. (19). ### Screening Bronchial Challenge All subjects underwent a standard methacholine (MCh) inhalation challenge to identify the occurrence of EFL, to establish the doses of MCh to be used for the subsequent Technegas studies, and to make sure that TLC did not change in any subject with induced bronchoconstriction. Aerosol MCh was administered by a dosimeter (MEFAR, Brescia, Italy) during tidal breathing. Doubling doses of MCh were obtained by changing the number of breaths and/or concentration. After inhalation of saline, the challenge started from 20 μg of MCh and ended when IC decreased beyond its natural variability, which was previously determined to be 9% and 220 ml (16), or when the noncumulative dose of 2,400 μg was achieved. At baseline and after each MCh dose, the subject performed the following set of maneuvers. First, a forced expiratory maneuver initiated with no hesitation from end-tidal inspiration (partial maneuver) was performed in the plethysmograph. Second, at least six regular breaths and a forced expiration from TLC (maximal maneuver) were recorded to compute IC, forced expiratory volume in 1 s (FEV1), and forced vital capacity. Finally, TLC was measured as above described. Forced expiratory flows from partial (V˙part) and maximal (V˙max) maneuvers were corrected for the amount of thoracic gas compressed. This was the volume difference between mouth flow vs. mouth volume and mouth flow vs. thoracic volume curves. The expiratory flow reserve was calculated as the difference between tidal and compression-free V˙part near FRC (V˙partFRC). The dose causing a decrease of FEV1 by 20% of baseline value was calculated by interpolation of the log dose-response curve. Furthermore, the following three MCh doses were identified: the dose that decreased V˙partFRC by ∼50% of baseline value leaving IC unchanged (*dose A*), the dose that completely abolished expiratory flow reserve without reducing IC beyond its natural variability (*dose B*), and the dose that also decreased IC beyond its natural variability (*dose C*). ### Assessment of EFL on the Study Days A DIREC/NEP System 200/201 (Raytech Instruments, Vancouver, BC, Canada) was used. Flow was measured at the mouth by a pneumotachograph (Hans-Rudolph 4700A, Kansas City, MO) connected to a differential pressure transducer (Validyne MP45 ±2 cmH2O). The occurrence of EFL was assessed by two methods. The first (partial flow method) was by comparing tidal flow with V˙part corrected for the amount of thoracic gas compressed at that same absolute lung volume as determined in the body plethysmograph during the screening bronchial challenge. After about eight regular breaths, the subject expired forcefully from end-tidal inspiration near RV, then inspired immediately to TLC and expired forcefully to RV. EFL was said to occur whenever tidal expiratory flow was equal toV˙partFRC. When IC was decreased, tidal flow andV˙partFRC were compared at baseline FRC (14,15). In the second method (NEP method) (11), a negative expiratory pressure (NEP) of 4 cmH2O was applied at the mouth during the expiratory phase of quiet breathing after at least six regular breaths. The expiratory port of the pneumotachograph was connected in series to an interrupter valve (model RV-003, S/N 1003; Aeromech Devices, Almonte, PQ, Canada), a Venturi device (Aeromech Devices), and a tank of compressed air. Pressure at the mouth was measured by a differential pressure transducer (Validyne DP15, ±150 cmH2O). The negative pressure was applied at regular intervals of ∼15 s over 1 min and for 0.2 s after the beginning of expiration and maintained until the next inspiration started. Care was taken that the subject was breathing regularly before the negative pressure was applied and that there were no air leaks around the mouthpiece. All digitized data were stored in a personal computer for subsequent analysis. EFL was said to occur if the flow generated after application of the negative pressure was not increased compared with previous breaths. ### Imaging Techniques Technegas was generated in a Technegas generator (Tetley Manufacturing, Sydney, Australia) according to the standard manufacturer's recommendations. The crucible was loaded with a standard dose of 370 MBq of 99mTc-pertechnectate. The subjects were connected to the Technegas generator through a system that included in series a mouthpiece, a Hans-Rudolph pneumotachograph, and a plastic device with inspiratory and expiratory ports, with the latter being connected to a resistive trap to collect exhaled radionuclear activity. Inhalation of Technegas was performed with the subjects in a sitting position and during 12 tidal breaths initiated from FRC. The reasons for using 12 tidal breaths instead of the more conventional 2–3 deep breaths were to avoid the effects of deep breaths on airway caliber especially during induced airway narrowing, to avoid inhomogeneous distribution of the radioisotope in the lung, and to allow radionuclear acquisitions during tidal breathing. Scintigraphic studies were performed by using a large field-of-view gamma camera (General Electric, 400AT) equipped with a low-energy high-resolution collimator. Dynamic radionuclear acquisition was performed in the posterior view every 0.25 s (matrix 64 × 64) during the inhalation of 99mTc-Technegas. Static acquisitions were performed in the posterior, anterior, and right and left posterior oblique views with a matrix size of 128 × 128; 300 kilocounts were accumulated for each image. Single-photon-emission computed tomography (SPECT) studies were done by rotating the gamma camera around the subject, who was lying supine and with the arms raised above his head. A total of 64 images (matrix 64 × 64) was acquired for 20 s each using a step-shoot method over 360° with 6° increment. Images acquired in the dynamic phase of the study were added to obtain a single image. A small square region of interest (3 × 3 pixel) was drawn around areas of high uptake of 99mTc-Technegas (“hot spot”) and a time-activity curve was obtained. The same region of interest was drawn on the control study for comparison. Analysis of the static planar scans was performed by use of a semiquantitative isocount method. Specifically, isocontours of the lungs were drawn according to three cutoff levels (15, 30, and 50% of maximal Technegas radioactivity) with the aid of a special software. The relevant subtended areas were estimated and will be referred to in the present paper as *area 15*, *area 30*, and*area 50*, respectively. The decrease in these areas after exposure to three different doses of MCh reflects the progressive and prevalent distribution of Technegas in the central regions of the lungs. Estimation of the above areas was also extended to the upper and lower zones of each lung after a horizontal line passing through the hylum was arbitrarily drawn. Transaxial SPECT images (2-pixel slice thickness) were obtained by the filtered backprojection method using a Butterworth filter (cutoff frequency = 0.4 cycles/cm; order no. 15). No attenuation correction was used. Coronal and sagittal images were generated from the transverse slices. SPECT images were used to locate and numerate the area of high activity (hot spots) generated after MCh administration. A hot spot was a well-defined small area with an activity higher than 50% of the activity present in the surrounding field. The numbers of hot spots present in each slice of coronal, sagittal, and transverse planes were identified. ### Study Design #### Study 1. Four subjects were studied on 2 days in random order. On *day 1*, lung function was evaluated at baseline by three sets of tidal, partial, and maximal inspiratory and expiratory maneuvers. Then, Technegas was inhaled during 12 tidal breaths with the subject seated in front of a gamma camera to record the posteroanterior scans at 4 Hz for a total of 1 min. Spirogram was synchronized with the scintigraphic scans to identify inspiratory and expiratory phases and to monitor the breathing pattern (Direc 3.1, Raytech Instruments, and ANADAT 5.1, RTH InfoDat, Montreal, Canada). Two minutes later, one more set of tidal, partial, and maximal inspiratory and expiratory maneuvers was recorded. On *day 2*, the procedures were repeated in the same order except that Technegas inhalation was preceded 3 min earlier by inhalation of the MCh *dose C* determined on the screening day. #### Study 2. Seven subjects were studied on 4 days in random order. On *day 1*, lung function was evaluated at baseline by three sets of NEP maneuvers and three sets of tidal, partial, and maximal inspiratory and expiratory maneuvers. Then, Technegas was inhaled during 12 tidal breaths with the pneumotachograph placed between the mouthpiece and the inhaler of the Technegas generator. One more set of NEP maneuvers and one of tidal, partial, and maximal inspiratory and expiratory maneuvers were measured 2 min later. On *days 2*, *3*, and*4*, the same sets of maneuvers were repeated at baseline, 2 min after one of the predetermined MCh doses (*A*,*B*, or *C*), and 2 min after Technegas inhalation. Soon after lung function measurements were terminated, posteroanterior, anteroposterior, and right and left oblique static scans were taken within 10 min and SPECT over the remaining 25 min of the study. Salbutamol (200 μg by metered dose inhaler) was allowed at the end of studies. ### Statistical Analysis Data are presented as means ± SD or geometric mean. Data were analyzed by paired *t*-test or ANOVA with Duncan post hoc comparisons whenever appropriate. *P* < 0.05 was considered statistically significant. ## RESULTS ### Study 1 There were no significant differences in lung function between the two study days (Table 2). On *day 1* (control), Technegas was fairly homogeneously distributed across both lungs in all but one individual, who showed a patchy and irregular distribution. No significant changes in lung function occurred after inhalation of Technegas. On *day 2*, inhalation of MCh*dose C* decreased V˙partFRC by ∼90% andV˙maxFRC by 70%, whereas IC decreased by 0.80 ± 0.46 liter. The breathing pattern during Technegas inhalation was similar to *day 1* (Table 3). Inhalation of Technegas after MCh was associated with inhomogeneous distribution of the isotope, with occurrence of many hot spots in the central areas of the lungs. View this table: [Table 2.](http://jap.physiology.org/content/91/5/2190/T2) Table 2. Functional data on days 1 (control) and 2 (MCh dose C) in the 4 subjects of study 1 View this table: [Table 3.](http://jap.physiology.org/content/91/5/2190/T3) Table 3. Breathing pattern during inhalation of Technegas in the 4 subjects of study 1 The time-activity curve of total counts on lung windows where the hot spots were maximum on *day 2* revealed substantially different deposition pattern between days (Fig. 1). On *day 1*, the curve was characterized by regular increments of radioactivity synchronous with inspiration and decrements with expiration. During each expiration, about half the counts recorded during the previous inspiratory phase remained in that area so that total radioactivity on the window tended to increase progressively with the number of breaths. In contrast, on *day 2* the increase in radioactivity synchronous with inspiration tended to be slightly less in the same region of control, likely due to airway narrowing and consequent decreased ventilation. Nevertheless, little or no decrease was documented during the next expiratory phase, thus suggesting that enhanced deposition of Technegas in the hot spots mostly occurred during expiration. ![Fig. 1.](http://jap.physiology.org/http://jap.physiology.org/content/jap/91/5/2190/F1.medium.gif) [Fig. 1.](http://jap.physiology.org/content/91/5/2190/F1) Fig. 1. Time-activity curves of total counts of Technegas on lung windows where the “hot spots” were maximum on *day 2* in the 4 cases (*A*–*D*) of *study 1*. On*day 1* (control) (thin lines), the curves are characterized by regular increments of radioactivity synchronous with tidal inspiration and decrements with tidal expiration. Total radioactivity of the window progressively increases with the number of breaths. Spirographic signals are not reported in the graph. On the day the airways are exposed to methacholine (MCh; thick lines), the increase in radioactivity synchronous with inspiration is followed by little or no decrease during the next expiratory phase, thus suggesting enhanced deposition of Technegas in the hot spots during expiration. ### Study 2 There were no significant differences in baseline lung function among study days (Table 4). One individual refused to continue the study after* days 1* and*2*. On *day 1* (control), deposition of Technegas was fairly uniform in the lung as visually documented on both static and SPECT scans, with the exception of the same subject mentioned in*study 1* in whom deposition of the isotope was once again slightly patchy. No changes in lung function occurred after inhaling Technegas. On *day 2*, V˙partFRC decreased after MCh in all subjects by 37 ± 12% without changes in IC. In no subjects was EFL identified using either the partial flow or the NEP method. Lung deposition of Technegas was less uniform, and some hot spots formed in each individual in the central airways, as documented by SPECT. On *day 3*, the decrease in lung function after MCh was such that the expiratory flow reserve was almost completely abolished in all subjects with no or slight decrease in IC. Again, no EFL was identified in any patient by either method. Deposition of Technegas became even more irregular than on *day 2*, and more hot spots occurred in the same areas. On *day 4*, airway obstruction was much more severe and so was the decrease in IC. Four patients showed EFL by the partial flow method and three by the NEP method. Static and SPECT scans documented a remarkable increased deposition of the isotope in the central airways with numerous hot spots. Peripheral deposition of the isotope became less evident in all the subjects, thus suggesting airway closure. Figure2 is a typical example of deposition of Technegas in the four sessions in one of the subjects. No significant differences in breathing pattern during Technegas inhalation were seen on any study days (Table 5), and inhalation of Technegas itself was never associated with changes in lung function (V˙partFRC, V˙maxFRC, and IC) (data not reported). View this table: [Table 4.](http://jap.physiology.org/content/91/5/2190/T4) Table 4. Functional data in the 7 subjects of study 2 ![Fig. 2.](http://jap.physiology.org/http://jap.physiology.org/content/jap/91/5/2190/F2.medium.gif) [Fig. 2.](http://jap.physiology.org/content/91/5/2190/F2) Fig. 2. Typical example of planar posteroanterior scans of the lungs in a subject after inhaling Technegas on *day 1* (control;*A*) and after increasing doses of doses of MCh (*B*–*D*). Note the enhanced distribution of the Technegas in the central areas of the lungs even with the smallest dose of constrictor agent. View this table: [Table 5.](http://jap.physiology.org/content/91/5/2190/T5) Table 5. Breathing pattern during inhalation of Technegas in study 2 Data on Technegas lung deposition are presented in Table6. Total count of the radioisotope was not significantly different within the four sessions, as expected if ventilation remains constant. There was however, a significant and progressive decrease of *areas 15*, *30*, and*50* with airway narrowing in both the upper and lower half of the lung, suggesting enhanced deposition of the isotope in the central regions of the lung and confirming the pattern visually identified on the static and SPECT scans. Typical distribution of the hot spots in the coronal, sagittal, and transverse sections in one subject is shown in Fig. 3. View this table: [Table 6.](http://jap.physiology.org/content/91/5/2190/T6) Table 6. Scintigraphic data of study 2 ![Fig. 3.](http://jap.physiology.org/http://jap.physiology.org/content/jap/91/5/2190/F3.medium.gif) [Fig. 3.](http://jap.physiology.org/content/91/5/2190/F3) Fig. 3. Distribution of the hot spots in the coronal (*A*), sagittal (*B*), and transverse (*C*) sections in the same subject of Fig. 2 with 80 (dotted lines), 400 (dashed lines), and 800 μg MCh (solid lines). The distribution of the spots is unimodal in the coronal and transverse sections and bimodal in the sagittal section, thus suggesting that the prevalent location of the spots is in the central rather than in the peripheral areas of the lungs. The decrease in number of spots with the highest dose of MCh is due to merging of small and separate spots into larger and bulgy ones. Ant, anteroposterior; Post, posteroanterior. ## DISCUSSION The main findings of the present study are that *1*) EFL during tidal breathing occurred across the lung well before expiratory flow reserve was completely abolished and *2*) methods based on mouth flow measurements were fairly insensitive to detect EFL occurring with induced airway narrowing even when dynamic hyperinflation was present. ### Comments on Methodology This study was based on the comparative analysis of two methodologies, i.e., Technegas lung deposition and measurement of expiratory flow reserve. Technegas is an aerosol of99mTc-labeled carbon molecules with small diameter (<0.01 μm) (5), capable of depositing even in the most peripheral regions of the lung (3) depending on a number of factors. Among them are the volume at which inhalation is initiated, the pattern of breathing, and airway geometry and patency. Inhalation from FRC in our study was chosen because we intended to identify EFL in the range of tidal breathing and also because it minimizes vertical differences in isotope distribution across the lung (3,7). The latter was fairly evident on all control sessions of both studies except in an individual in whom a slightly low FEV1 (i.e., 85% of predicted) was associated with patchy distribution of the radioisotope. Breathing pattern during the 12 tidal breaths could have an effect on the deposition of Technegas in the airways due to inertial impaction of the particles when flow velocity increases and eddies form in the large airways (22). However, even though the plastic device connecting the Technegas chamber to the subject offers a perceptible resistance to breathing, tidal volume as well as inspiratory and expiratory flows remained substantially similar in the four sessions. ### Comments on Results In theory, with the assumption that airway narrowing is not a homogeneous phenomenon and inspiratory flow remains constant, as it did in our study, the velocity of gas increases during inspiration when bronchial lumen narrows, and so does the inertial impaction. Therefore, it would not be unrealistic to expect formation of hot spots during inspiration. During expiration, however, the airways tend to change caliber more than during inspiration and to collapse where choke points exist. Under these circumstances, acceleration of gas and of the radioactive particles traveling with it would increase out of proportion, especially where narrowing is more pronounced. Eddies forming at the exit of the narrow segments would favor trapping and deposition of the particles on the luminal surface by an extent reasonably greater than during inspiration. The findings of *study 1* would lend support to this mechanism in that total counts on the lung windows with hot spots increased during inspiration similarly to control conditions of *day 1* but remained high on expiration. Such a pattern would suggest that the hot spots mostly represent exaggerated deposition of Technegas occurring in the airways when narrowing is sufficiently severe to cause flow limitation during tidal expiration. This interpretation does not, however, exclude the possibility that other mechanisms may contribute to generate spotty and enhanced distribution of Technegas under these conditions. As documented by the static and SPECT images and by the progressive decrease in *areas 15*, *30*, and *50*, the hot spots always formed in the same regions around the hylum and increased in number or merged with the contiguous ones with the increase of MCh dose. During forced expiration, the flow-limiting segment is known to be located first in the large intrathoracic airways and then to move peripherally although hardly ever beyond subsegmental bronchi (9). Our scintigraphic techniques could not precisely define the anatomical location of the flow-limiting segments during tidal breathing. Yet all the hot spots recorded during tidal breathing were apparently located in the large airways, as reported during cough (20, 21). We speculate that intrinsic anatomical and/or functional differences among parallel airways (13) cause EFL to manifest inhomogeneously across the lung with respect to space and time. Flow at the mouth during forced expiration is the ultimate result of the emptying of all alveolar units. Its monotonic and fairly linear decrease with lung volume in healthy conditions is in apparent contrast with the above-mentioned structural and functional heterogeneities of the respiratory system, which would tend to desynchronize flows from contiguous sectors. Nevertheless, there are dynamic mechanisms that solidly oppose such regional flow discrepancies (13, 24). Lung emptying during tidal expiration is, on the contrary, a smooth and slow process relatively independent of lung inhomogeneities because it takes place over a time well within the expiratory time imposed by the respiratory drive. Exposing the lung to a bronchoconstrictor agent may cause variable narrowing across the airways, with at the extremes little change in caliber in some airways and severe obstruction associated with occurrence of flow limitation in others. The ensuing decrease in maximum flow is therefore due to any sort of combination of increased frictional losses upstream from the flow-limiting segment in some airways and premature occurrence of EFL in others. Comparing tidal to maximal flow in the tidal breathing range, as done in the present study, documented a progressive decrease in expiratory flow reserve but categorically let regional onset of EFL remain unnoticed until obstruction was so severe that all or most airways were flow limited and the expiratory flow reserve fell to zero. On the basis of these observations, we may depict the following possible scenario. After exposure of the lung to low doses of a bronchoconstrictor agent, most of the airways slightly decrease caliber. Surprisingly, however, few of them already manifest exaggerated narrowing up to the point that maximal flow was achieved. The effect of the latter is trivial on maximum flow due to compensatory mechanisms opposing and limiting regional inhomogeneities. The expiratory flow reserve under these conditions is still variably present. Further doses of the bronchoactive agent narrow the range of airway response because most or all the central airways manifest dynamic collapse during tidal expiration. Under this condition, increasing expiratory effort as during forced expiration or applying a negative pressure does not produce additional flow because all central airways are flow limited. Thus the complete abolishment of expiratory flow reserve indisputably suggests that EFL has involved all lung regions. In one subject, the NEP method did not identify the presence of EFL on *day 4*, whereas the partial flow method did. The reason for this is simply that some individuals tend to slightly overdistend the lungs in response to EFL during a bronchial challenge. Therefore, any comparison of tidal to maximal flow that does not consider increase in FRC may miss the presence of EFL. This study gave us the opportunity to document two other aspects of airflow obstruction with the highest dose of MCh. First, in all the cases we saw on the SPECT scans that Technegas was totally missing in an entire lobe or part of it, mostly in the dependent lung regions and when constriction was severe. In our view, this may be attributed to full airway closure. Under this condition, airway opening pressure is so high that it cannot be achieved during tidal inspiration. The finding is consistent with studies demonstrating the insufficiency of forces of interdependence between airways and surrounding lung parenchyma to prevent full closure in the airways most vulnerable to narrowing (4, 8). Second, it is well known that, when EFL occurs, FRC increases to contrast and limit airway obstruction (17). What one would expect from our study is that the increase in FRC at the transition from the intermediate to the highest dose of MCh in *study 2* could counteract EFL and modulate airway narrowing. Surprisingly, we found further decrease in expiratory flow and greater numbers of hot spots, which would apparently speak against a fully protective role of lung hyperinflation during bronchoconstriction. We speculate that airway narrowing and EFL would have certainly been intolerable for the subjects and so shortness of breath would have occurred had FRC remained fixed at baseline values. Thus it appears that increased external elastic load with lung hyperinflation has strong yet limited dilator effects on airways. A finding of practical importance was that EFL was undetected by either partial flow or NEP method when IC was decreased. In a previous study our laboratory documented that FRC increases mostly when EFL occurs (14). Others (23) found an increased FRC even when EFL could not be detected by the NEP method. They concluded that mechanisms other than EFL cause dynamic hyperinflation during induced bronchoconstriction. The present findings of a significant decrease in IC well before EFL could be detected by methods based on mouth flow measurements suggest that the reported dissociation between dynamic hyperinflation and EFL was due to the low sensitivity of the method used to assess EFL. To further investigate the relevance of the present findings to overall lung mechanics, dynamic elastance (Edyn) was measured in a single subject during tidal breathing on *days 2*, *3*, and*4* of *study 2*. As in a previous study (15), Edyn progressively increased after each MCh dose (Fig. 4) but was already increased on*days 2* and *3*, when IC was still unchanged. This suggests that regional EFL may contribute to increase in Edyn during mild induced bronchoconstriction. We speculate that lung regions served by airways under EFL may become overinflated, thus contributing to the increase in Edyn, as observed with the small doses of constrictor agent in the present study. This mechanism does not exclude the possibility that also undetected airway closure may contribute to increase Edyn under similar circumstances by diverting flow to overdistended lung regions. Clearly, at the highest levels of obstruction an additional increment of Edyn may occur because of airway closure, increase in FRC, and stress relaxation (18). ![Fig. 4.](http://jap.physiology.org/http://jap.physiology.org/content/jap/91/5/2190/F4.medium.gif) [Fig. 4.](http://jap.physiology.org/content/91/5/2190/F4) Fig. 4. Dynamic elastance (Edyn) before (B) and after (A) MCh on*days 2*, *3*, and *4* of *study 2*in a subject who accepted to have lung mechanics measured. Values are means ± SD of 8 tidal breaths. Edyn was computed by using the ANADAT 5.1 software (RTH InfoDat, Montreal, PQ) with esophageal and mouth pressures being measured by 2 identical separate differential pressure transducers (DP15, ±150 cmH2O, Validyne). Positioning of an esophageal balloon, filled with 1 ml of air, was made after topical anesthesia and was considered correct if transpulmonary pressure did not change after a gentle expiratory effort against a partially occluded port. Note the progressive increase in Edyn with the different doses of MCh. In conclusion, the present study supports the notion that EFL during spontaneous breathing in asthma is time and space dependent. Implicit with this assertion is that EFL occurs well before the usual methods based on measurements of mouth flow can detect it. ## Acknowledgments This work was supported in part by a grant from Ministero dell'Universitá della Recerca Scientifica e Tecnologica, Rome, Italy. ## Footnotes * Address for reprint requests and other correspondence: V. Brusasco, Dipartimento di Scienze Motorie e Riabilitative, Università di Genova, Largo R. Benzi, 10, 16132 Genova, Italy (E-mail: brusasco{at}dism.unige.it). * The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “*advertisement*” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. * Copyright © 2001 the American Physiological Society ## REFERENCES 1. American Thoracic Society (1962) Chronic bronchitis, asthma and pulmonary emphysema. Am Rev Respir Dis 84:762–768. 2. American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144:1202–1218. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1164/ajrccm/144.5.1202&link_type=DOI) [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=1952453&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A1991GP08200035&link_type=ISI) 3. Amis TC, Crawford ABH, Davison A, Engel LA. (1990) Distribution of inhaled 99mtechnetium labelled ultrafine carbon particle aerosol (Technegas) in human lungs. Eur Respir J 3:679–685. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=erj&resid=3/6/679&atom=%2Fjap%2F91%2F5%2F2190.atom) 4. Brown RH, Mitzner W. (2000) Airway closure with high PEEP in vivo. J Appl Physiol 89:956–960. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=89/3/956&atom=%2Fjap%2F91%2F5%2F2190.atom) 5. Burch WM, Sullivan PJ, McLaren CJ. (1986) Technegas: a new ventilation agent for lung scanning. Nucl Med Commun 7:865–871. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1097/00006231-198612000-00003&link_type=DOI) [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=3033569&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A1986F493900003&link_type=ISI) 6. Crawford ABH, Davison A, Amis TC, Engel LA. (1990) Intrapulmonary distribution of 99mtechnetium labelled ultrafine carbon aerosol (Technegas) in severe airflow obstruction. Eur Respir J 3:686–692. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=erj&resid=3/6/686&atom=%2Fjap%2F91%2F5%2F2190.atom) 7. Dollfuss RE, Milic-Emili J, Bates DV. (1967) Regional ventilation of the lung studied with boluses of 133xenon. Respir Physiol 2:234–246. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1016/0034-5687(67)90057-6&link_type=DOI) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A19679120500012&link_type=ISI) 8. Gunst SJ, Warner D, Wilson TA, Hyatt RE. (1988) Parenchymal interdependence and airway response to methacholine in excised dog lobes. J Appl Physiol 65:2490–2497. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=65/6/2490&atom=%2Fjap%2F91%2F5%2F2190.atom) 9. Hyatt RE.Forced expiration.Handbook of Physiology. The Respiratory System. Mechanics of Breathing.1986Am. Physiol. SocBethesda, MD, sect. 3, vol. III, pt. 1, chapt. 19, p. 295–314. 10. King GG, Eberl S, Salome CM, Meikle SR, Woolcock AJ. (1997) Airway closure measured by a Technegas bolus and SPECT. Am J Respir Crit Care Med 155:682–688. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1164/ajrccm.155.2.9032213&link_type=DOI) [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=9032213&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A1997WH87100044&link_type=ISI) 11. Koulouris NG, Valta P, Lavoie A, Corbeil C, Chassé M, Braidy J, Milic-Emili J. (1995) A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 8:306–313. [Abstract](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=erj&resid=8/2/306&atom=%2Fjap%2F91%2F5%2F2190.atom) 12. Lemb M, Oei TH, Eifert H, Gunther B. (1993) Technegas: a study of particle structure, size and distribution. Eur J Nucl Med 20:576–579. [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=8053994&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A1993LN25000002&link_type=ISI) 13. McNamara JJ, Castile RG, Glass GM, Fredberg JJ. (1987) Heterogeneous lung emptying during forced expiration. J Appl Physiol 63:1648–1657. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=63/4/1648&atom=%2Fjap%2F91%2F5%2F2190.atom) 14. Pellegrino R, Violante B, Nava S, Rampulla C, Brusasco V, Rodarte JR. (1993) Expiratory airflow limitation and hyperinflation during methacholine-induced bronchoconstriction. J Appl Physiol 75:1720–1727. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=75/4/1720&atom=%2Fjap%2F91%2F5%2F2190.atom) 15. Pellegrino R, Wilson O, Jenouri G, Rodarte JR. (1996) Lung mechanics during induced bronchoconstriction. J Appl Physiol 81:964–975. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=81/2/964&atom=%2Fjap%2F91%2F5%2F2190.atom) 16. Pellegrino R, Rodarte JR, Brusasco V. (1998) Assessing the reversibility of airway obstruction. Chest 114:1607–1612. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1378/chest.114.6.1607&link_type=DOI) [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=9872196&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=000077613600023&link_type=ISI) 17. Pride NB, Macklem PT.Lung mechanics in disease.Handbook of Physiology. The Respiratory System. Mechanics of Breathing.1986Am. Physiol. SocBethesda, MD, sect. 3, vol. III, pt. 2, chapt. 38, p. 659–692. 18. Rodarte JR, Noredin G, Miller C, Brusasco V, Pellegrino R. (1999) Lung elastic recoil during breathing at increased lung volume. J Appl Physiol 87:1491–1495. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=87/4/1491&atom=%2Fjap%2F91%2F5%2F2190.atom) 19. Quanjer PH, Tammeling GJ, Cotes FE, Pedersen OF, Peslin R, Yernault J-C. (1993) Standardized lung function testing. Eur Respir J 6:1–99. 20. Smaldone GC, Itoh H, Swift DL, Wagner HN Jr.. (1979) Effect of flow-limiting segments and cough on particle deposition and mucociliary clearance in the lung. Am Rev Respir Dis 120:747–758. [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=507506&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A1979HR91900004&link_type=ISI) 21. Smaldone GC, Messina MS. (1985) Enhancement of particle deposition by flow-limiting segments in humans. J Appl Physiol 59:509–514. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=59/2/509&atom=%2Fjap%2F91%2F5%2F2190.atom) 22. Stuart BO. (1973) Deposition of inhaled aerosols. Arch Intern Med 131:60–73. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1001/archinte.1973.00320070056006&link_type=DOI) [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=4569374&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A1973O614800005&link_type=ISI) 23. Tantucci C, Ellaffi M, Duguet A, Zelter M, Similowski T, Derenne JP, Milic-Emili J. (1999) Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma. Eur Respir J 14:295–301. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=erj&resid=14/2/295&atom=%2Fjap%2F91%2F5%2F2190.atom) 24. Wilson TA, Fredberg JJ, Rodarte JR, Hyatt RE. (1985) Interdependence of regional expiratory flow. J Appl Physiol 59:1924–1928. [Abstract/FREE Full Text](http://jap.physiology.org/lookup/ijlink?linkType=ABST&journalCode=jap&resid=59/6/1924&atom=%2Fjap%2F91%2F5%2F2190.atom) 25. Woolcock AJ, Read J. (1966) Lung volume in exacerbations of asthma. Am J Med 41:259–273. [CrossRef](http://jap.physiology.org/lookup/external-ref?access_num=10.1016/0002-9343(66)90021-0&link_type=DOI) [PubMed](http://jap.physiology.org/lookup/external-ref?access_num=5912303&link_type=MED&atom=%2Fjap%2F91%2F5%2F2190.atom) [Web of Science](http://jap.physiology.org/lookup/external-ref?access_num=A19668110200010&link_type=ISI)